| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000080 | Mitotic g1 phase | Affects phenotype | PMID:35678645 |
| GO:0000084 | Mitotic s phase | Increases phenotype | PMID:29094436; PMID:29846718; PMID:32700164 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Affects phenotype | PMID:29094436; PMID:32700164 |
| GO:0000278 | Mitotic cell cycle | Affects phenotype | PMID:29094436 |
| GO:0001541 | Ovarian follicle development | Affects phenotype | PMID:36152675 |
| GO:0001545 | Primary ovarian follicle growth | Decreases phenotype | PMID:39141488 |
| GO:0001547 | Antral ovarian follicle growth | Decreases phenotype | PMID:35104888 |
| GO:0001553 | Luteinization | Decreases phenotype | PMID:28219760 |
| GO:0001556 | Oocyte maturation | Decreases phenotype | PMID:36723383 |
| GO:0001780 | Neutrophil homeostasis | Affects phenotype | PMID:31904477 |
| GO:0001821 | Histamine secretion | Increases phenotype | PMID:27682001 |
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:25586001 |
| GO:0001892 | Embryonic placenta development | Affects phenotype | PMID:32074459 |
| GO:0001967 | Suckling behavior | Affects phenotype | PMID:36105436 |
| GO:0002024 | Diet induced thermogenesis | Increases phenotype | PMID:26001964 |
| GO:0002082 | Regulation of oxidative phosphorylation | Affects phenotype | PMID:36436258 |
| GO:0002250 | Adaptive immune response | Decreases phenotype | PMID:32227269 |
| GO:0002253 | Activation of immune response | Decreases phenotype | PMID:32227269 |
| GO:0002309 | T cell proliferation involved in immune response | Affects phenotype | PMID:31904477 |
| GO:0002316 | Follicular b cell differentiation | Affects phenotype | PMID:37162486 |
| GO:0002381 | Immunoglobulin production involved in immunoglobulin-mediated immune response | Increases phenotype | PMID:27682001 |
| GO:0002437 | Inflammatory response to antigenic stimulus | Increases phenotype | PMID:27682001 |
| GO:0002455 | Humoral immune response mediated by circulating immunoglobulin | Decreases phenotype | PMID:22274686; PMID:26041029 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:23626681; PMID:23626681; PMID:26054880; PMID:35066053; PMID:26054880 |
| GO:0002534 | Cytokine production involved in inflammatory response | Increases phenotype | PMID:27682001 |
| GO:0002553 | Histamine secretion by mast cell | Increases phenotype | PMID:27682001 |
| GO:0002637 | Regulation of immunoglobulin production | Affects phenotype | PMID:37162486 |
| GO:0003006 | Developmental process involved in reproduction | Decreases phenotype | PMID:34171588 |
| GO:0003016 | Respiratory system process | Decreases phenotype | PMID:30737192 |
| GO:0003094 | Glomerular filtration | Decreases phenotype | PMID:23482063; PMID:26590127; PMID:27529882 |
| GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity | Decreases phenotype | PMID:29156323 |
| GO:0004465 | Lipoprotein lipase activity | Increases phenotype | PMID:30657992 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:26054880; PMID:33422635; PMID:39933620 |
| GO:0004984 | Olfactory receptor activity | Affects phenotype | PMID:38513818 |
| GO:0005243 | Gap junction channel activity | Decreases phenotype | PMID:26023933; PMID:32971237 |
| GO:0005978 | Glycogen biosynthetic process | Decreases phenotype | PMID:28947262 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:32892005; PMID:33325755; PMID:33993001 |
| GO:0006011 | Udp-glucose metabolic process | Affects phenotype | PMID:33325755 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:33325755 |
| GO:0006094 | Gluconeogenesis | Affects phenotype | PMID:28947262 |
| GO:0006101 | Citrate metabolic process | Affects phenotype | PMID:33325755 |
| GO:0006108 | Malate metabolic process | Affects phenotype | PMID:33325755 |
| GO:0006110 | Regulation of glycolytic process | Affects phenotype | PMID:37236338 |
| GO:0006111 | Regulation of gluconeogenesis | Affects phenotype | PMID:37236338 |
| GO:0006119 | Oxidative phosphorylation | Affects phenotype | PMID:34311058; PMID:39933620 |
| GO:0006171 | Camp biosynthetic process | Increases phenotype | PMID:28947262 |
| GO:0006306 | Dna methylation | Increases phenotype | PMID:32700164 |
| GO:0006309 | Apoptotic dna fragmentation | Increases phenotype | PMID:31841032 |
| GO:0006531 | Aspartate metabolic process | Affects phenotype | PMID:33325755 |
| GO:0006536 | Glutamate metabolic process | Affects phenotype | PMID:33325755; PMID:33569802; PMID:34029635 |
| GO:0006544 | Glycine metabolic process | Affects phenotype | PMID:33325755 |
| GO:0006551 | Leucine metabolic process | Affects phenotype | PMID:33325755; PMID:34029635 |
| GO:0006558 | L-phenylalanine metabolic process | Affects phenotype | PMID:34029635 |
| GO:0006560 | Proline metabolic process | Affects phenotype | PMID:33325755 |
| GO:0006568 | Tryptophan metabolic process | Affects phenotype | PMID:33325755; PMID:34029635 |
| GO:0006570 | Tyrosine metabolic process | Affects phenotype | PMID:34029635 |
| GO:0006580 | Ethanolamine metabolic process | Affects phenotype | PMID:33325755 |
| GO:0006600 | Creatine metabolic process | Affects phenotype | PMID:33325755 |
| GO:0006601 | Creatine biosynthetic process | Decreases phenotype | PMID:38123106 |
| GO:0006629 | Lipid metabolic process | Affects phenotype | PMID:32634666; PMID:33113464; PMID:33325755 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:33325755; PMID:34029635; PMID:36436258 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:31931806; PMID:32074459; PMID:32588087; PMID:34464680; PMID:34464680; PMID:38182912; PMID:38117326; PMID:38182912 |
| GO:0006672 | Ceramide metabolic process | Increases phenotype | PMID:34627976 |
| GO:0006684 | Sphingomyelin metabolic process | Affects phenotype | PMID:32634666 |
| GO:0006694 | Steroid biosynthetic process | Affects phenotype | PMID:33991873 |
| GO:0006695 | Cholesterol biosynthetic process | Affects phenotype | PMID:20123614; PMID:25092180; PMID:30508572 |
| GO:0006699 | Bile acid biosynthetic process | Affects phenotype | PMID:32253466; PMID:33991873 |
| GO:0006702 | Androgen biosynthetic process | Affects phenotype | PMID:30508572 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:33325755; PMID:33422635; PMID:34029635 |
| GO:0006853 | Carnitine shuttle | Decreases phenotype | PMID:30508572 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:32578922; PMID:35123991 |
| GO:0006915 | Apoptotic process | Affects phenotype | PMID:26054880; PMID:29846718; PMID:32971237; PMID:33422635; PMID:35123991; PMID:35563431; PMID:37044272 |
| GO:0006954 | Inflammatory response | Decreases phenotype | PMID:32916415 |
| GO:0006955 | Immune response | Affects phenotype | PMID:31904477 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:32320774 |
| GO:0006979 | Response to oxidative stress | Affects phenotype | PMID:34029635 |
| GO:0007005 | Mitochondrion organization | Increases phenotype | PMID:34311058 |
| GO:0007049 | Cell cycle | Affects phenotype | PMID:40347494 |
| GO:0007286 | Spermatid development | Decreases phenotype | PMID:31841032 |
| GO:0007346 | Regulation of mitotic cell cycle | Affects phenotype | PMID:38603627 |
| GO:0007595 | Lactation | Decreases phenotype | PMID:27179585 |
| GO:0007610 | Behavior | Affects phenotype | PMID:25567242 |
| GO:0007612 | Learning | Affects phenotype | PMID:32521479 |
| GO:0008121 | Ubiquinol-cytochrome-c reductase activity | Increases phenotype | PMID:25586001 |
| GO:0008137 | Nadh dehydrogenase (ubiquinone) activity | Increases phenotype | PMID:25586001 |
| GO:0008177 | Succinate dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:25586001 |
| GO:0008202 | Steroid metabolic process | Affects phenotype | PMID:37422089 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:19846564; PMID:32971418; PMID:26942110; PMID:32253466 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:36436258 |
| GO:0008216 | Spermidine metabolic process | Affects phenotype | PMID:34029635 |
| GO:0008219 | Cell death | Affects phenotype | PMID:26599974; PMID:27682001; PMID:37738295; PMID:39933616 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:23539207; PMID:23978341; PMID:26234195; PMID:29502166; PMID:29502166; PMID:32700164; PMID:35346789; PMID:35678645; PMID:37044272; PMID:37834465 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:25868421; PMID:28511854; PMID:35337807; PMID:36251517 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:30547568; PMID:32353385; PMID:34246126 |
| GO:0008361 | Regulation of cell size | Affects phenotype | PMID:32320774 |
| GO:0008610 | Lipid biosynthetic process | Increases phenotype | PMID:25092180 |
| GO:0008652 | Amino acid biosynthetic process | Affects phenotype | PMID:34029635 |
| GO:0009117 | Nucleotide metabolic process | Affects phenotype | PMID:34029635 |
| GO:0009437 | Carnitine metabolic process | Affects phenotype | PMID:33325755 |
| GO:0009636 | Response to toxic substance | Affects phenotype | PMID:23458897 |
| GO:0010172 | Embryonic body morphogenesis | Decreases phenotype | PMID:34134420 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Affects phenotype | PMID:33356526; PMID:35266797; PMID:39862910 |
| GO:0010468 | Regulation of gene expression | Affects phenotype | PMID:26978841; PMID:37738295 |
| GO:0010507 | Negative regulation of autophagy | Increases phenotype | PMID:37806615 |
| GO:0010634 | Positive regulation of epithelial cell migration | Increases phenotype | PMID:36849026 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:28219760 |
| GO:0010867 | Positive regulation of triglyceride biosynthetic process | Affects phenotype | PMID:34252412 |
| GO:0010884 | Positive regulation of lipid storage | Increases phenotype | PMID:32353385 |
| GO:0010890 | Positive regulation of sequestering of triglyceride | Increases phenotype | PMID:28049043 |
| GO:0010907 | Positive regulation of glucose metabolic process | Increases phenotype | PMID:36115532 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:38513818 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Increases phenotype | PMID:34311058 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:23626681; PMID:25868421; PMID:26879310; PMID:34246126 |
| GO:0014049 | Positive regulation of glutamate secretion | Increases phenotype | PMID:33027616 |
| GO:0015711 | Organic anion transport | Affects phenotype | PMID:28552774 |
| GO:0015808 | L-alanine transport | Decreases phenotype | PMID:33027616 |
| GO:0015825 | L-serine transport | Increases phenotype | PMID:33027616 |
| GO:0015920 | Lipopolysaccharide transport | Increases phenotype | PMID:35066053 |
| GO:0015939 | Pantothenate metabolic process | Affects phenotype | PMID:33325755 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:26054880; PMID:33422635 |
| GO:0016049 | Cell growth | Increases phenotype | PMID:26234195; PMID:29502166; PMID:29721586; PMID:30144469 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:29502166; PMID:32700164; PMID:29753068; PMID:29753068; PMID:33571556; PMID:33571556; PMID:35346789 |
| GO:0019216 | Regulation of lipid metabolic process | Affects phenotype | PMID:31931806; PMID:37236338; PMID:38513818 |
| GO:0019217 | Regulation of fatty acid metabolic process | Affects phenotype | PMID:37236338 |
| GO:0019369 | Arachidonic acid metabolic process | Affects phenotype | PMID:33991873 |
| GO:0019432 | Triglyceride biosynthetic process | Affects phenotype | PMID:25092180; PMID:29094436 |
| GO:0019530 | Taurine metabolic process | Affects phenotype | PMID:33325755 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:34958885 |
| GO:0019673 | Gdp-mannose metabolic process | Affects phenotype | PMID:33325755 |
| GO:0019674 | Nad metabolic process | Affects phenotype | PMID:33325755 |
| GO:0019752 | Carboxylic acid metabolic process | Affects phenotype | PMID:34029635 |
| GO:0019858 | Cytosine metabolic process | Affects phenotype | PMID:34029635 |
| GO:0019859 | Thymine metabolic process | Affects phenotype | PMID:34029635 |
| GO:0021846 | Cell proliferation in forebrain | Decreases phenotype | PMID:40347494 |
| GO:0021895 | Cerebral cortex neuron differentiation | Decreases phenotype | PMID:40347494 |
| GO:0022008 | Neurogenesis | Affects phenotype | PMID:23948355 |
| GO:0030282 | Bone mineralization | Affects phenotype | PMID:26058082; PMID:34585601; PMID:35750749 |
| GO:0030307 | Positive regulation of cell growth | Increases phenotype | PMID:30711707 |
| GO:0030308 | Negative regulation of cell growth | Increases phenotype | PMID:30711707; PMID:36341878 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:35370244 |
| GO:0030431 | Sleep | Decreases phenotype | PMID:39512894 |
| GO:0030501 | Positive regulation of bone mineralization | Increases phenotype | PMID:33033332 |
| GO:0030879 | Mammary gland development | Affects phenotype | PMID:35163327 |
| GO:0031324 | Negative regulation of cellular metabolic process | Increases phenotype | PMID:36251517 |
| GO:0031325 | Positive regulation of cellular metabolic process | Increases phenotype | PMID:25868421; PMID:36251517 |
| GO:0031331 | Positive regulation of cellular catabolic process | Increases phenotype | PMID:30685356 |
| GO:0031398 | Positive regulation of protein ubiquitination | Increases phenotype | PMID:26879310 |
| GO:0031507 | Heterochromatin formation | Increases phenotype | PMID:26339649 |
| GO:0031987 | Locomotion involved in locomotory behavior | Affects phenotype | PMID:36105436 |
| GO:0032204 | Regulation of telomere maintenance | Affects phenotype | PMID:34454526 |
| GO:0032275 | Luteinizing hormone secretion | Decreases phenotype | PMID:39141488 |
| GO:0032640 | Tumor necrosis factor production | Increases phenotype | PMID:27682001 |
| GO:0032691 | Negative regulation of interleukin-1 beta production | Increases phenotype | PMID:35065522 |
| GO:0032755 | Positive regulation of interleukin-6 production | Affects phenotype | PMID:23458897 |
| GO:0032760 | Positive regulation of tumor necrosis factor production | Increases phenotype | PMID:39141488 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:28511854 |
| GO:0033023 | Mast cell homeostasis | Affects phenotype | PMID:31904477 |
| GO:0033540 | Fatty acid beta-oxidation using acyl-coa oxidase | Increases phenotype | PMID:30711707 |
| GO:0034109 | Homotypic cell-cell adhesion | Decreases phenotype | PMID:37044272 |
| GO:0034379 | Very-low-density lipoprotein particle assembly | Decreases phenotype | PMID:30657992 |
| GO:0034389 | Lipid droplet organization | Increases phenotype | PMID:23626681 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:25586001; PMID:28219760; PMID:39933620 |
| GO:0035929 | Steroid hormone secretion | Decreases phenotype | PMID:35104888 |
| GO:0035934 | Corticosterone secretion | Increases phenotype | PMID:29721586 |
| GO:0035936 | Testosterone secretion | Increases phenotype | PMID:35104888 |
| GO:0035937 | Estrogen secretion | Affects phenotype | PMID:39933620 |
| GO:0035938 | Estradiol secretion | Decreases phenotype | PMID:35104888 |
| GO:0035942 | Dehydroepiandrosterone secretion | Decreases phenotype | PMID:27219028 |
| GO:0035943 | Estrone secretion | Decreases phenotype | PMID:35104888 |
| GO:0036109 | Alpha-linolenic acid metabolic process | Affects phenotype | PMID:33991873 |
| GO:0036123 | Histone h3-k9 dimethylation | Decreases phenotype | PMID:32700164 |
| GO:0036343 | Psychomotor behavior | Affects phenotype | PMID:32272335 |
| GO:0040029 | Epigenetic regulation of gene expression | Affects phenotype | PMID:39862910 |
| GO:0042098 | T cell proliferation | Increases phenotype | PMID:31904477 |
| GO:0042100 | B cell proliferation | Decreases phenotype | PMID:31904477 |
| GO:0042133 | Neurotransmitter metabolic process | Affects phenotype | PMID:34029635 |
| GO:0042403 | Thyroid hormone metabolic process | Increases phenotype | PMID:25483837; PMID:26517287; PMID:33243245 |
| GO:0042448 | Progesterone metabolic process | Affects phenotype | PMID:30508572 |
| GO:0042572 | Retinol metabolic process | Affects phenotype | PMID:33991873 |
| GO:0042593 | Glucose homeostasis | Affects phenotype | PMID:36964247 |
| GO:0042632 | Cholesterol homeostasis | Decreases phenotype | PMID:18000414; PMID:20819969; PMID:23685825; PMID:23441227; PMID:30657992; PMID:32822737; PMID:36174755 |
| GO:0042697 | Menopause | Increases phenotype | PMID:21411548; PMID:39510233; PMID:27529882 |
| GO:0042701 | Progesterone secretion | Decreases phenotype | PMID:34311058; PMID:35104888; PMID:39933620 |
| GO:0042756 | Drinking behavior | Affects phenotype | PMID:26001964 |
| GO:0042866 | Pyruvate biosynthetic process | Increases phenotype | PMID:28947262 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:28219760; PMID:33812015; PMID:34765786 |
| GO:0043303 | Mast cell degranulation | Increases phenotype | PMID:27682001 |
| GO:0043396 | Corticotropin-releasing hormone secretion | Increases phenotype | PMID:33824413 |
| GO:0043651 | Linoleic acid metabolic process | Affects phenotype | PMID:33991873 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:29094436; PMID:31809754; PMID:32068100; PMID:36336871; PMID:32253466; PMID:32971237; PMID:33422635; PMID:33569802; PMID:34029635; PMID:34311058; PMID:35123991; PMID:35346789; PMID:36326898; PMID:36336871; PMID:36613676; PMID:36864359; PMID:37044272; PMID:38117326; PMID:38549690 |
| GO:0044255 | Cellular lipid metabolic process | Affects phenotype | PMID:34464680 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:29753068 |
| GO:0044565 | Dendritic cell proliferation | Increases phenotype | PMID:31904477 |
| GO:0045023 | G0 to g1 transition | Affects phenotype | PMID:32700164 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:34800597; PMID:39111555 |
| GO:0045540 | Regulation of cholesterol biosynthetic process | Affects phenotype | PMID:29156323 |
| GO:0045541 | Negative regulation of cholesterol biosynthetic process | Increases phenotype | PMID:36115532 |
| GO:0045577 | Regulation of b cell differentiation | Affects phenotype | PMID:37162486 |
| GO:0045719 | Negative regulation of glycogen biosynthetic process | Increases phenotype | PMID:35066053; PMID:36115532 |
| GO:0045730 | Respiratory burst | Increases phenotype | PMID:36788734 |
| GO:0045772 | Positive regulation of autophagosome size | Increases phenotype | PMID:26879310 |
| GO:0045793 | Positive regulation of cell size | Increases phenotype | PMID:28049043 |
| GO:0045834 | Positive regulation of lipid metabolic process | Increases phenotype | PMID:34627976 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:26879310 |
| GO:0046031 | Adp metabolic process | Affects phenotype | PMID:33325755 |
| GO:0046033 | Amp metabolic process | Affects phenotype | PMID:33325755 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:25586001; PMID:33325755; PMID:34029635; PMID:34311058; PMID:39933620 |
| GO:0046036 | Ctp metabolic process | Affects phenotype | PMID:33325755 |
| GO:0046039 | Gtp metabolic process | Affects phenotype | PMID:33325755 |
| GO:0046048 | Udp metabolic process | Affects phenotype | PMID:33325755 |
| GO:0046051 | Utp metabolic process | Affects phenotype | PMID:33325755 |
| GO:0046083 | Adenine metabolic process | Affects phenotype | PMID:33325755 |
| GO:0046085 | Adenosine metabolic process | Affects phenotype | PMID:33325755 |
| GO:0046098 | Guanine metabolic process | Affects phenotype | PMID:34029635 |
| GO:0046104 | Thymidine metabolic process | Affects phenotype | PMID:33325755 |
| GO:0046108 | Uridine metabolic process | Affects phenotype | PMID:33325755 |
| GO:0046167 | Glycerol-3-phosphate biosynthetic process | Affects phenotype | PMID:33325755 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:36336871 |
| GO:0046323 | Glucose import | Decreases phenotype | PMID:34311058 |
| GO:0046415 | Urate metabolic process | Affects phenotype | PMID:36174755 |
| GO:0046459 | Short-chain fatty acid metabolic process | Affects phenotype | PMID:30813950 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:33812015 |
| GO:0046470 | Phosphatidylcholine metabolic process | Affects phenotype | PMID:32634666 |
| GO:0046483 | Heterocycle metabolic process | Affects phenotype | PMID:34029635 |
| GO:0046622 | Positive regulation of organ growth | Increases phenotype | PMID:30685356; PMID:30711707; PMID:30711707 |
| GO:0046704 | Cdp metabolic process | Affects phenotype | PMID:33325755 |
| GO:0046710 | Gdp metabolic process | Affects phenotype | PMID:33325755 |
| GO:0046890 | Regulation of lipid biosynthetic process | Affects phenotype | PMID:34500360 |
| GO:0046961 | Proton-transporting atpase activity, rotational mechanism | Decreases phenotype | PMID:34029635 |
| GO:0048487 | Beta-tubulin binding | Decreases phenotype | PMID:36181250 |
| GO:0048589 | Developmental growth | Decreases phenotype | PMID:27553991 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Increases phenotype | PMID:26054880 |
| GO:0050890 | Cognition | Affects phenotype | PMID:32272335 |
| GO:0051462 | Regulation of cortisol secretion | Affects phenotype | PMID:37236338 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Increases phenotype | PMID:25586001; PMID:34029635; PMID:35123991; PMID:37044272; PMID:37834465; PMID:39933620 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:39933620 |
| GO:0051899 | Membrane depolarization | Increases phenotype | PMID:37044272 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:27682001 |
| GO:0055088 | Lipid homeostasis | Decreases phenotype | PMID:32353385 |
| GO:0060208 | Proestrus | Decreases phenotype | PMID:39141488 |
| GO:0060326 | Cell chemotaxis | Increases phenotype | PMID:32700164; PMID:33571556; PMID:35346789 |
| GO:0060612 | Adipose tissue development | Increases phenotype | PMID:27352404 |
| GO:0061028 | Establishment of endothelial barrier | Decreases phenotype | PMID:33571556 |
| GO:0061052 | Negative regulation of cell growth involved in cardiac muscle cell development | Increases phenotype | PMID:34134420 |
| GO:0061516 | Monocyte proliferation | Increases phenotype | PMID:31904477 |
| GO:0070091 | Glucagon secretion | Affects phenotype | PMID:36613676 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:23948355 |
| GO:0070316 | Regulation of g0 to g1 transition | Affects phenotype | PMID:38603627 |
| GO:0070328 | Triglyceride homeostasis | Decreases phenotype | PMID:20819969; PMID:30657992; PMID:30711707 |
| GO:0070858 | Negative regulation of bile acid biosynthetic process | Increases phenotype | PMID:38181850 |
| GO:0070873 | Regulation of glycogen metabolic process | Affects phenotype | PMID:37236338 |
| GO:0071736 | Igg immunoglobulin complex, circulating | Decreases phenotype | PMID:27501995 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:25586001; PMID:34029635; PMID:35123991; PMID:36336871; PMID:39933620 |
| GO:0080182 | Histone h3-k4 trimethylation | Decreases phenotype | PMID:32700164 |
| GO:0090030 | Regulation of steroid hormone biosynthetic process | Affects phenotype | PMID:37236338 |
| GO:0090116 | C-5 methylation of cytosine | Decreases phenotype | PMID:32068100; PMID:32320774 |
| GO:0090181 | Regulation of cholesterol metabolic process | Affects phenotype | PMID:30657992 |
| GO:0090207 | Regulation of triglyceride metabolic process | Affects phenotype | PMID:30657992 |
| GO:0090208 | Positive regulation of triglyceride metabolic process | Increases phenotype | PMID:34627976 |
| GO:0090592 | Dna synthesis involved in dna replication | Increases phenotype | PMID:30711707 |
| GO:0097153 | Cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:34029635 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:31841032 |
| GO:0098609 | Cell-cell adhesion | Decreases phenotype | PMID:23948355 |
| GO:0110119 | Positive regulation of very-low-density lipoprotein particle clearance | Increases phenotype | PMID:30657992 |
| GO:0120190 | Negative regulation of bile acid secretion | Increases phenotype | PMID:38181850 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:29094436; PMID:32320774; PMID:38182912; PMID:32353385; PMID:34464680; PMID:36251517; PMID:39778647 |
| GO:1900103 | Positive regulation of endoplasmic reticulum unfolded protein response | Increases phenotype | PMID:36251517 |
| GO:1900533 | Palmitic acid metabolic process | Affects phenotype | PMID:33325755 |
| GO:1901098 | Positive regulation of autophagosome maturation | Decreases phenotype | PMID:26879310 |
| GO:1901164 | Negative regulation of trophoblast cell migration | Increases phenotype | PMID:32219433; PMID:35548680 |
| GO:1901216 | Positive regulation of neuron death | Increases phenotype | PMID:33027616 |
| GO:1901334 | Lactone metabolic process | Affects phenotype | PMID:34029635 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Decreases phenotype | PMID:28219760 |
| GO:1901713 | Negative regulation of urea catabolic process | Increases phenotype | PMID:38123106 |
| GO:1902807 | Negative regulation of cell cycle g1/s phase transition | Increases phenotype | PMID:38513818 |
| GO:1902884 | Positive regulation of response to oxidative stress | Increases phenotype | PMID:36849026 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:32700164; PMID:35678645 |
| GO:1903052 | Positive regulation of proteolysis involved in protein catabolic process | Decreases phenotype | PMID:26879310 |
| GO:1903180 | Negative regulation of dopamine biosynthetic process | Increases phenotype | PMID:34371090 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:33812015 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:28511854; PMID:34765786; PMID:36075290; PMID:36251517; PMID:38513818 |
| GO:1903851 | Negative regulation of cristae formation | Increases phenotype | PMID:33812015 |
| GO:1903998 | Regulation of eating behavior | Affects phenotype | PMID:26001964 |
| GO:1904177 | Regulation of adipose tissue development | Affects phenotype | PMID:36436258 |
| GO:1904178 | Negative regulation of adipose tissue development | Increases phenotype | PMID:30711707; PMID:36115532 |
| GO:1904197 | Positive regulation of granulosa cell proliferation | Increases phenotype | PMID:38603627 |
| GO:1904253 | Positive regulation of bile acid metabolic process | Increases phenotype | PMID:34627976 |
| GO:1904358 | Positive regulation of telomere maintenance via telomere lengthening | Increases phenotype | PMID:34193151 |
| GO:1990182 | Exosomal secretion | Increases phenotype | PMID:37851381 |
| GO:1990402 | Embryonic liver development | Affects phenotype | PMID:36436258 |
| GO:1990403 | Embryonic brain development | Decreases phenotype | PMID:40347494 |
| GO:1990428 | Mirna transport | Increases phenotype | PMID:37851381 |
| GO:1990959 | Eosinophil homeostasis | Affects phenotype | PMID:31904477 |
| GO:2000045 | Regulation of g1/s transition of mitotic cell cycle | Affects phenotype | PMID:29502166 |
| GO:2000064 | Regulation of cortisol biosynthetic process | Affects phenotype | PMID:37236338 |
| GO:2000180 | Negative regulation of androgen biosynthetic process | Increases phenotype | PMID:38050817 |
| GO:2000609 | Regulation of thyroid hormone generation | Affects phenotype | PMID:29488882; PMID:32311629 |
| GO:2000614 | Positive regulation of thyroid-stimulating hormone secretion | Increases phenotype | PMID:26517287 |
| GO:2000726 | Negative regulation of cardiac muscle cell differentiation | Increases phenotype | PMID:34134420 |
| GO:2000786 | Positive regulation of autophagosome assembly | Increases phenotype | PMID:26879310; PMID:38513818 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:38603627 |
| GO:2000872 | Positive regulation of progesterone secretion | Affects phenotype | PMID:28219760; PMID:38603627 |
| GO:2001057 | Reactive nitrogen species metabolic process | Affects phenotype | PMID:36336871 |
| GO:2001170 | Negative regulation of atp biosynthetic process | Increases phenotype | PMID:38513818 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.